This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysis Of The United States Bone Grafts And Bone Graft Substitutes Market

NEW YORK, April 2, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Analysis of the United States Bone Grafts and Bone Graft Substitutes Market

This research service considers products and companies in the bone grafts and bone graft substitutes market in the United States. This market expects to witness many technology advancements in the next decade. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the market's various segments including: machine allografts, standard allografts, demineralized bone matrix, bone morphogenetic proteins (BMP), bone graft substitutes, and platelet concentration systems markets. Market engineering measurements, drivers, and restraints are covered along with an analysis of the market's highly competitive landscape. The base year is 2011; the forecast period extends through 2016.

Executive Summary•Total revenue generated by sales of bone grafts and bone graft substitutes in the United States (U.S.) in 2011 was approximately $xxmillion, representing a xx percent decrease over 2010.•Revenue in the U.S. bone grafts and bone graft substitute market is projected to grow at a compound annual growth rate (CAGR) ofxx percent from 2011 to 2016, reaching $xx million in 2016.•The segment with the highest CAGR is the cell-based matrices market, followed closely by the demineralized bone matrix (DBM) market.•The decrease in the growth rate for the bone morphogenetic protein (BMP) market has been one of the biggest factors leading to the decline in the overall market. This is the largest segment in the entire market.•As new clinical data is published and innovation continues, the market is expected to slowly get back to larger market growth numbers.•The market is mostly controlled by large manufacturers, but there are low barriers to entries in the niche segments.

TABLE OF CONTENTS Executive Summary 4Market Overview 9Total Bone Grafts and Bone Graft Substitutes Market -•External Challenges: Drivers and Restraints 19•Forecast and Trends 28•Competitive Analysis 36Machined Bone Allograft Segment Breakdown 41Standard Bone Allograft Segment Breakdown 52DBM Segment Breakdown 63Bone Graft Substitutes Segment Breakdown 75BMP Segment Breakdown 91Cell-based Matrices Segment Breakdown 104Platelet Concentration System Segment Breakdown 116The Last Word (Conclusions and Implications) 127Appendix 129

To order this report:: Analysis of the United States Bone Grafts and Bone Graft Substitutes Market


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs